Swiss Transplant Cohort Study

All Transplanted Individuals in Switzerland Clinical Trial

— STCS  

Official title:

Swiss Transplant Cohort Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01204944
• Other study ID #: 3347C0-108795/1
• Status: Recruiting
• Start date: May 2008
• Est. completion date: May 2028

Study information

• Verified date: November 2023
• Source: University of Zurich
• Contact: 01 Studienregister MasterAdmins
• Phone: +41 (0)44 255 11 11
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The Swiss Transplant Cohort Study is an observational prospective cohort study enrolling all patients after solid organ and stem cell transplantation since 5/2008 in Switzerland. Predefined variables are collected at defined time points. Individual samples (PBMC, plasma, DNA) will be stored for future projects. Data relevant to transplantation outcome with emphasis on immunological and infectious complications as well as psychosocial variables will be gathered.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 7500
• Est. completion date: May 2028
• Est. primary completion date: May 2028
• Accepts healthy volunteers: No
• Gender: All
• Age group: 0 Years to 100 Years

Eligibility

Inclusion criteria:

• All patients after organ and stem cell (planned 2009) transplantation.

Exclusion criteria:

• No informed consent given

Related Conditions & MeSH terms

• All Transplanted Individuals in Switzerland

Locations

Country	Name	City	State
n/a

Sponsors (6)

Lead Sponsor	Collaborator
University of Zurich	Cantonal Hospital of St. Gallen, University Hospital, Geneva, University of Basel, University of Bern, University of Lausanne

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Outcome after transplantation	Various endpoints	open